Clal Biotechnology Industries Ltd (CBI) — Net Asset Momentum
Clal Biotechnology Industries Ltd (CBI) recorded a net asset momentum of -62.0% as of December 2024, with net assets of ILA46.16 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CBI cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Clal Biotechnology Industries Ltd Net Asset Momentum (2006–2024)
This chart tracks Clal Biotechnology Industries Ltd's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is -62.0%, with net assets of ILA46.16 Million ILA as of December 2024. Read Clal Biotechnology Industries Ltd total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Clal Biotechnology Industries Ltd (2006–2024)
The table below shows the complete annual net asset history for Clal Biotechnology Industries Ltd from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see CBI market cap overview.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ILA46.16 Million | ILA67.69 Million | ILA21.52 Million | ▼ -62.0% |
| 2023 | ILA121.41 Million | ILA158.39 Million | ILA36.98 Million | ▼ -16.2% |
| 2022 | ILA144.90 Million | ILA182.69 Million | ILA37.79 Million | ▼ -57.2% |
| 2021 | ILA338.37 Million | ILA444.92 Million | ILA106.55 Million | ▼ -34.1% |
| 2020 | ILA513.79 Million | ILA614.03 Million | ILA100.24 Million | ▲ +3.2% |
| 2019 | ILA497.85 Million | ILA616.97 Million | ILA119.12 Million | ▼ -42.6% |
| 2018 | ILA867.62 Million | ILA1.02 Billion | ILA148.46 Million | ▲ +7.4% |
| 2017 | ILA808.20 Million | ILA1.03 Billion | ILA226.14 Million | ▲ +7.4% |
| 2016 | ILA752.50 Million | ILA1.12 Billion | ILA366.21 Million | ▼ -31.1% |
| 2015 | ILA1.09 Billion | ILA1.53 Billion | ILA440.31 Million | ▼ -13.2% |
| 2014 | ILA1.26 Billion | ILA1.69 Billion | ILA428.44 Million | ▼ -8.8% |
| 2013 | ILA1.38 Billion | ILA1.92 Billion | ILA540.45 Million | ▼ -1.0% |
| 2012 | ILA1.40 Billion | ILA1.75 Billion | ILA354.19 Million | ▲ +25.9% |
| 2011 | ILA1.11 Billion | ILA1.25 Billion | ILA142.01 Million | ▼ -9.6% |
| 2010 | ILA1.23 Billion | ILA1.36 Billion | ILA138.20 Million | ▲ +56.6% |
| 2009 | ILA782.91 Million | ILA936.32 Million | ILA153.41 Million | ▲ +185.3% |
| 2008 | ILA274.45 Million | ILA425.92 Million | ILA151.47 Million | ▼ -11.3% |
| 2007 | ILA309.49 Million | ILA420.47 Million | ILA110.98 Million | ▲ +166.2% |
| 2006 | ILA116.28 Million | ILA128.78 Million | ILA12.50 Million | — |